PCMS_Philadelphia_Medicine_Summer2017 - 12
p h i l a m e d s o c .org
FEATURE
P h ila d e lp h ia Ta sk Fo rce Rep o r t o n Op io id Ep id emic
EQUIANALGESIC
Opioid
Equivalency
Table
(morphine, oral)
Analgesic
Equivalent dose
Strength
(10 mg oral
(relative)
morphine)
Bioavailability
Half-life of active
metabolites
(hours)
Acetaminophen (nonopioid)
1⁄360
3600 mg
63-89%
Aspirin (NSAID, nonopioid)
1⁄360
3600 mg
80-100%
3.1-9
Ibuprofen[7] (NSAID,
non-opioid)
1⁄222
2220 mg
87-100%
1.3-3
Diflunisal (NSAID, nonopioid) (Dolobid)
1⁄160
1600 mg
80-90%
8-12
Naproxen[7] (NSAID,
non-opioid)
1⁄138
1380 mg
95%
12-24
Diclofenac[7] [8](NSAID,
non-opioid)
1⁄14 (est.) 160 mg (est.)
50-60%
1-4
Dextropropoxyphene[9]
(Darvocet)
1⁄13- 1⁄20
130-200 mg
Codeine
1⁄10
180 mg (PO)
≈90%
2.5-3
(C6G 1.94;[10] morphine
2-3)
1⁄10
>200 mg
75% (IR), 85-90%
6.0-8.8[11] (M1)
(ER)
Opium (oral)
1⁄10
≈100 mg
≈35%
2.5-3.0
(morphine, codeine)
Dihydrocodeine
1
⁄ 5
50 mg
20%
4
1
10 mg
≥80%
3.8-6
1
10 mg
≈25%
1.5
6.67 mg
≤87%
3-4.5
3
3.33 mg
100%
2-3
Tramadol
Hydrocodone
Morphine (oral)
Oxycodone
[15]
Morphine (IV/IM)
Methadone (acute)
[16][17]
2.5-3.33 mg
40-90%
15-60
Methadone (chronic)[17] 2.5-5
3.33 mg
40-90%
15-60
Diamorphne (heroin
IV/IM)18
4-5
2-2.5 mg
100%
<0.6
Fentanyl
50-100
0.1 mg (100 μg)
IM/IV
33% (SL); 92%
(TD)
0.04 (IV); 7 (TD)
Carfentanil[20]
10,000-
100,000
0.1-1.0 μg
7.7
References[edit]
1. a b Joishy, S. K. (1999). Palliative medicine secrets. Philadelphia PA:
Hanley & Belfus. p. 97. ISBN 1-56053-304-8.
2. McPherson, Mary Lynn M. (2000). Demystifying Opioid Conversion
Calculations: A Guide for Effective Dosing. Bethesda MD: American Society
of Health-System Pharmacists. p. 5. ISBN 1-58528-198-0.
3. McPherson 2000, p. 3
4. McPherson 2000, p. 4
5. McPherson 2000, p. 8
6. McPherson 2000, p. 9
7. a b c "Dosing Guidelines for Acetaminophen and Selected NSAIDs"
(PDF). www3.us.elsevierhealth.com.
8. ttp://www.emedexpert.com/compare-meds/diclofenac-vs-naproxen.shtml
9. a b "Ch. 4 Narcotics: Synthetic Narcotics: Dextropropoxyphene". Drugs of
Abuse. Drug Enforcement Administration, U.S. Department of Justice. 2005.
10. KuKanich B (February 2010). "Pharmacokinetics of acetaminophen,
codeine, and the codeine metabolites morphine and codeine-6-glucuronide
12 Philadelphia Medicine : Summer 2017
Opioid equivalency table summarized from
https://en.wikipedia.org/wiki/Equianalgesic
3-4
in healthy Greyhound dogs". J. Vet. Pharmacol. Ther. 33 (1): 15-21.
doi:10.1111/j.1365-2885.2009.01098.x. PMC 2867071 . PMID
20444020.
11. "ULTRAM® (tramadol hydrochloride) Tablets Full Prescribing Information"
(PDF). US Food and Drug Administration. Ortho-McNeil Pharmaceutical,
Inc. March 2008. p. 4. Retrieved December 28, 2016. The mean terminal
plasma elimination half-lives of racemic tramadol and racemic M1 are 6.3
± 1.4 and 7.4 ± 1.4 hours, respectively. The plasma elimination half-life
of racemic tramadol increased from approximately six hours to seven hours
upon multiple dosing.
12. Anileridine". DrugBank Version: 3.0. DrugBank.
13. Equianalgesic Dosing of Opioids for Pain Management" (PDF).
August 2012.
14. "TALWIN (pentazocine lactate) injection, solution". DailyMed. National
Institute of Health. Retrieved 2011-12-10.
15. a b "Equianalgesic Conversion". GlobalRPH.
16. J Tabla de equivalencia opiáceos
17. a b Manfredonia JF (March 2005). "Prescribing methadone for pain
management in end-of-life care". J Am Osteopath Assoc. 105 (3 Suppl 1):
S18-21. PMID 18 154194. Table 2: Conversion Ratio of Oral Morphine
to Methadone.
18. Reichle CW, Smith GM, Gravenstein JS, Macris SG, Beecher HK (April
1962). "Comparative analgesic potency of heroin and morphine in postoperative
patients". J. Pharmacol. Exp. Ther. 136 (1): 43-6. PMID 14491157.
19. Paul Walker. "MORPHINE vs HYDROMORPHINE vs OXYCODONE
vs THE PATCH". Archived from the original on December 24, 2001.
20. a b "Levorphanol". DrugBank Version: 3.0. DrugBank.
21. Ohmori, Satoshi; Morimoto, Yasunori (2002). "Dihydroetorphine: a
potent analgesic: pharmacology, toxicology, pharmacokinetics, and clinical
effects". CNS drug reviews. 8 (4): 391-404. ISSN 1080-563X. PMID
12481194. Dihydroetorphine (DHE) is one of the strongest analgesic opioid
alkaloids known; it is 1000 to 12,000 times more potent than morphine. ...
MOR is the most commonly used opioid analgesic for pain relief, and its
oral daily dose (20 to 1000 mg) is relatively high (44).
https://philamedsoc.org/
https://en.wikipedia.org/wiki/Equianalgesic
Table of Contents for the Digital Edition of PCMS_Philadelphia_Medicine_Summer2017
PCMS_Philadelphia_Medicine_Summer2017 - 1
PCMS_Philadelphia_Medicine_Summer2017 - 2
PCMS_Philadelphia_Medicine_Summer2017 - 3
PCMS_Philadelphia_Medicine_Summer2017 - 4
PCMS_Philadelphia_Medicine_Summer2017 - 5
PCMS_Philadelphia_Medicine_Summer2017 - 6
PCMS_Philadelphia_Medicine_Summer2017 - 7
PCMS_Philadelphia_Medicine_Summer2017 - 8
PCMS_Philadelphia_Medicine_Summer2017 - 9
PCMS_Philadelphia_Medicine_Summer2017 - 10
PCMS_Philadelphia_Medicine_Summer2017 - 11
PCMS_Philadelphia_Medicine_Summer2017 - 12
PCMS_Philadelphia_Medicine_Summer2017 - 13
PCMS_Philadelphia_Medicine_Summer2017 - 14
PCMS_Philadelphia_Medicine_Summer2017 - 15
PCMS_Philadelphia_Medicine_Summer2017 - 16
PCMS_Philadelphia_Medicine_Summer2017 - 17
PCMS_Philadelphia_Medicine_Summer2017 - 18
PCMS_Philadelphia_Medicine_Summer2017 - 19
PCMS_Philadelphia_Medicine_Summer2017 - 20
PCMS_Philadelphia_Medicine_Summer2017 - 21
PCMS_Philadelphia_Medicine_Summer2017 - 22
PCMS_Philadelphia_Medicine_Summer2017 - 23
PCMS_Philadelphia_Medicine_Summer2017 - 24
PCMS_Philadelphia_Medicine_Summer2017 - 25
PCMS_Philadelphia_Medicine_Summer2017 - 26
PCMS_Philadelphia_Medicine_Summer2017 - 27
PCMS_Philadelphia_Medicine_Summer2017 - 28
PCMS_Philadelphia_Medicine_Summer2017 - 29
PCMS_Philadelphia_Medicine_Summer2017 - 30
PCMS_Philadelphia_Medicine_Summer2017 - 31
PCMS_Philadelphia_Medicine_Summer2017 - 32
PCMS_Philadelphia_Medicine_Summer2017 - 33
PCMS_Philadelphia_Medicine_Summer2017 - 34
PCMS_Philadelphia_Medicine_Summer2017 - 35
PCMS_Philadelphia_Medicine_Summer2017 - 36
PCMS_Philadelphia_Medicine_Summer2017 - 37
PCMS_Philadelphia_Medicine_Summer2017 - 38
PCMS_Philadelphia_Medicine_Summer2017 - 39
PCMS_Philadelphia_Medicine_Summer2017 - 40
https://www.nxtbook.com/hoffmann/PCMS_Philadelphia_Medicine/PhiladelphiaMedicine_Fall2021
https://www.nxtbook.com/hoffmann/PCMS_Philadelphia_Medicine/PhiladelphiaMedicine_Summer2021
https://www.nxtbook.com/hoffmann/PCMS_Philadelphia_Medicine/PhiladelphiaMedicineWinterSpring2021
https://www.nxtbook.com/hoffmann/PCMS_Philadelphia_Medicine/PhiladelphiaMedicine_Fallr2020
https://www.nxtbook.com/hoffmann/PCMS_Philadelphia_Medicine/PhiladelphiaMedicine_Summer2020
https://www.nxtbook.com/hoffmann/PCMS_Philadelphia_Medicine/PhiladelphiaMedicine_Spring2020
https://www.nxtbook.com/hoffmann/PCMS_Philadelphia_Medicine/PhiladelphiaMedicineFallWinter2019
https://www.nxtbook.com/hoffmann/PCMS_Philadelphia_Medicine/PhiladelphiaMedicine_Summer2019
https://www.nxtbook.com/hoffmann/PCMS_Philadelphia_Medicine/PhiladelphiaMedicine_Spring2019
https://www.nxtbook.com/hoffmann/PCMS_Philadelphia_Medicine/PhiladelphiaMedicine_Winter2019
https://www.nxtbook.com/hoffmann/PCMS_Philadelphia_Medicine/PhiladelphiaMedicine_Fall2018
https://www.nxtbook.com/hoffmann/PCMS_Philadelphia_Medicine/PhiladelphiaMedicine_Summer2018
https://www.nxtbook.com/hoffmann/PCMS_Philadelphia_Medicine/PhiladelphiaMedicine_Spring2018
https://www.nxtbook.com/hoffmann/PCMS_Philadelphia_Medicine/PhiladelphiaMedicine_Winter2017x
https://www.nxtbook.com/hoffmann/PCMS_Philadelphia_Medicine/PhiladelphiaMedicine_Fall2017
https://www.nxtbook.com/hoffmann/PCMS_Philadelphia_Medicine/PhiladelphiaMedicine_Summer2017
https://www.nxtbook.com/hoffmann/PCMS_Philadelphia_Medicine/PCMS_Philadelphia_Medicine_Spring2017
https://www.nxtbookmedia.com